Published in Nat Med on September 01, 2008
Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours. Hugo J (2011) 1.13
Hoechst-IR: an imaging agent that detects necrotic tissue in vivo by binding extracellular DNA. Org Lett (2010) 0.98
Comparison of KRAS Mutation Assessment in Tumor DNA and Circulating Free DNA in Plasma and Serum Samples. Clin Med Insights Pathol (2012) 0.94
DNA markers in molecular diagnostics for hepatocellular carcinoma. Expert Rev Mol Diagn (2014) 0.80
Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation. PLoS One (2011) 0.80
Evaluation of INK4A promoter methylation using pyrosequencing and circulating cell-free DNA from patients with hepatocellular carcinoma. Clin Chem Lab Med (2014) 0.79
Imaging DNA with fluorochrome bearing metals. Inorg Chem (2013) 0.75
Circulating mutant DNA to assess tumor dynamics. Nat Med (2007) 10.33
Radiological and clinical outcomes of using Chartis™ to plan endobronchial valve treatment. Eur Respir J (2012) 2.07
Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature. Clin Chim Acta (2010) 1.73
SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma. J Thorac Oncol (2011) 1.17
SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates. BMC Cancer (2010) 1.12
Changes in concentration of DNA in serum and plasma during storage of blood samples. Clin Chem (2003) 1.10
Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates. Int J Oncol (2011) 1.06
Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Respir Med (2008) 1.00
Proof of Principle studies. Epilepsy Res (2006) 0.94
Evaluation of carisbamate, a novel antiepileptic drug, in photosensitive patients: an exploratory, placebo-controlled study. Epilepsy Res (2007) 0.93
Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumors. BMC Cancer (2011) 0.92
A novel method for sensitive and specific detection of DNA methylation biomarkers based on DNA restriction during PCR cycling. Biotechniques (2009) 0.92
Improved method for isolating cell-free DNA. Clin Chem (2005) 0.91
Free circulating nucleic acids in plasma and serum (CNAPS) -- Useful for the detection of lung cancer patients? Cancer Biomark (2010) 0.90
The role of DNA methylation as biomarkers in the clinical management of lung cancer. Expert Rev Respir Med (2013) 0.89
Loss of body cell mass in Cushing's syndrome: effect of treatment. J Clin Endocrinol Metab (2002) 0.87
Increased spontaneous interleukin-10 release from alveolar macrophages in active pulmonary sarcoidosis. Exp Lung Res (2003) 0.87
Integrity of cell-free plasma DNA in patients with lung cancer and nonmalignant lung disease. Ann N Y Acad Sci (2008) 0.87
Respiratory function in late-onset Pompe disease patients receiving long-term enzyme replacement therapy for more than 48 months. Wien Med Wochenschr (2012) 0.86
Comparison of phenotypic methods for the identification of Candida dubliniensis. J Microbiol Immunol Infect (2010) 0.86
An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids. Ann N Y Acad Sci (2008) 0.85
Bronchoalveolar lavage fluid of lung cancer patients: mapping the uncharted waters using proteomics technology. Lung Cancer (2011) 0.84
Complement factor H is elevated in bronchoalveolar lavage fluid and sputum from patients with lung cancer. Cancer Epidemiol Biomarkers Prev (2010) 0.84
Methods for isolation of cell-free plasma DNA strongly affect DNA yield. Clin Chim Acta (2011) 0.83
Therapeutic implication of BAL in patients with neutropenia. Ann Hematol (2009) 0.81
Quantification of free RNA in serum and bronchial lavage: a new diagnostic tool in lung cancer detection? Lung Cancer (2004) 0.79
Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy. Epilepsy Res (2003) 0.79
A comparison of white light laryngostroboscopy versus autofluorescence endoscopy in the evaluation of vocal fold pathology. Laryngoscope (2013) 0.78
A short olefin metathesis-based route to enantiomerically pure arylated dihydropyrans and alpha, beta-unsaturated delta-valero lactones. J Org Chem (2003) 0.78
Detection of cell-free DNA in bronchial lavage fluid supernatants of patients with lung cancer. Ann N Y Acad Sci (2004) 0.76
The catalytic performance of Ru-NHC alkylidene complexes: PCy₃versus pyridine as the dissociating ligand. Beilstein J Org Chem (2010) 0.76
Radiologic manifestations of bronchoscopic lung volume reduction in severe chronic obstructive pulmonary disease. AJR Am J Roentgenol (2015) 0.76
Microsatellite alterations in free-circulating serum DNA in patients with ulcerative colitis. Dig Dis (2003) 0.76
Ultraflex expandable metallic stents: difficulties in benign tracheal stenoses. Ann Thorac Surg (2003) 0.75
Systematic Investigation into the Matsuda-Heck Reaction of α-Methylene Lactones: How Conformational Constraints Direct the β-H-Elimination Step. J Org Chem (2016) 0.75
TP53 gene in blood plasma DNA of tumor patients. Ann N Y Acad Sci (2004) 0.75
Taming of Ga droplets on DLC layers--size tuning and local arrangement with nanometer accuracy. Nanotechnology (2012) 0.75
Integration of thin-film-fracture-based nanowires into microchip fabrication. Small (2008) 0.75
Mature mediastinal teratoma with subtotal unidirectional pancreatic differentiation. Pathol Res Pract (2010) 0.75